Fecal microbiota: all 119 studies that test it

Page 1 of 2. Open to participants first (34), then studies with results posted, then the rest; newest registration first within each.

• Ecosystem Nourishment for Gut Restoration After Fecal TransplantationNot yet recruitingNCT07826793Phase 2
• A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHDNot yet recruitingNCT07756255Phase 2
• FMT for Pediatric SR-aGVHDRecruitingNCT07602751Phase 1/2
• Intestinal Microbiota Transplantation for Treating Advanced Tumor CachexiaNot yet recruitingNCT07533227Phase 2
• Fecal Microbiota Transplant vs Standard Treatment for Recurrent Non-Obstructive CholangitisNot yet recruitingNCT07509346Phase 2
• Fecal Microbiota Transplantation Among Adult Patients With Hematological MalignanciesEnrolling by invitationNCT07172191Not applicable
• A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic SclerosisRecruitingNCT06827977Phase 2
• Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive DisorderRecruitingNCT06692361Not applicable
• Fecal MicrobiotaTransplant for the Treatment of Parkinson's DiseaseNot yet recruitingNCT06647277Phase 1
• Fecal Microbiota Transplant for Anorexia NervosaNot yet recruitingNCT06593366Not applicable
• FMT for Alcohol Use Disorder in Cirrhotics.RecruitingNCT06496191Not applicable
• Fecal Microbiota Transplantation in Axial SpondyloarthritisRecruitingNCT06451588Phase 2
• Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)RecruitingNCT06321536Phase 2
• Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS)RecruitingNCT06201182Not applicable
• Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant EnterobacteriaceaeNot yet recruitingNCT05981430Not applicable
• Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial OvergrowthRecruitingNCT05967871Phase 1
• Fecal Microbiota Transplant for Patients With Chronic PouchitisRecruitingNCT05829109Early Phase 1
• Fecal Microbial Transplantation for Rheumatoid Arthritis TrialRecruitingNCT05790356Not applicable
• Superdonor FMT in Patients With Ulcerative ColitisRecruitingNCT05739864Phase 1/2
• Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile InfectionRecruitingNCT05709184Not applicable
• Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)RecruitingNCT05690048Phase 2
• Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).RecruitingNCT05664113Phase 1
• Effect of Gut Microbiome Intervention on Aging Via Oral FMTRecruitingNCT05598112Early Phase 1
• Fecal Microbiota Transplantation for Irritable Bowel Syndrome Associated Food IntoleranceRecruitingNCT05361785Not applicable
• Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes MellitusRecruitingNCT05253768Phase 2
• Microbial Restoration in Inflammatory Bowel DiseasesRecruitingNCT04970446Phase 1/2
• Faecal Microbiota Transplantation for Liver CirrhosisRecruitingNCT04932577Phase 2/3
• Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum DisordersNot yet recruitingNCT04630847Phase 1
• A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseRecruitingNCT04521205Phase 1
• Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained AtherosclerosisRecruitingNCT04410003Phase 1
• Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative ColitisRecruitingNCT04373473Phase 2
• Fecal Microbiota Transplantation for EpilepsyRecruitingNCT02889627Phase 2/3
• Fecal Microbiome TransplantEnrolling by invitationNCT02636517Phase 1
• Stool Transplants to Treat Refractory Clostridium Difficile ColitisRecruitingNCT02127398Phase 2
• A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)TerminatedNCT05153499Phase 3Results posted
• Fecal Microbiota Transplant for Primary CDITerminatedNCT03795233Phase 1/2Results posted
• Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)TerminatedNCT03720392Phase 2Results posted
• A Study of FMT in Patients With AML Allo HSCT in RecipientsCompletedNCT03678493Phase 2Results posted
• Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile InfectionCompletedNCT03497806Phase 2Results posted
• Fecal Microbiota Transplantation (FMT) for MDRO UTICompletedNCT03367910Phase 1/2Results posted
• Fecal Microbial Transplantation in Relapsing Multiple Sclerosis PatientsTerminatedNCT03183869Phase 2Results posted
• Fecal Microbiota Transplant for Improvement of MetabolismCompletedNCT02530385Phase 1/2Results posted
• Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)TerminatedNCT02417974Phase 2Results posted
• A Prospective Trial of Frozen-and-Thawed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile InfectionTerminatedNCT02394275Phase 2Results posted
• Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's ColitisCompletedNCT02330653Phase 1/2Results posted
• Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated DiarrheaCompletedNCT02318992Phase 1/2Results posted
• FMT Versus Antimicrobials for Initial Treatment of Recurrent CDITerminatedNCT02255305Phase 2Results posted
• Aging Resilience Through Microbiota Optimization and RegulationActive, not recruitingNCT06649981Phase 1
• Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot StudyCompletedNCT06022406Phase 2
• The Efficacy and Safty of FMT in Patients With CIDCompletedNCT05917379Phase 1/2
• CP101 for the Treatment of Ulcerative ColitisActive, not recruitingNCT05852574Phase 1
• Sentinel Cohort REACTCompletedNCT05780801Phase 1
• Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal DisordersTerminatedNCT05753774Phase 3
• Effect of Intensive FMT on Primary HypertensionStatus unknownNCT05608447Phase 1
• FMT Capsules in Treatment of Patients With Insomnia Clinical ResearchStatus unknownNCT05427331Not applicable
• Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical RespondersActive, not recruitingNCT05286294Phase 2
• Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of GI-aGVHDStatus unknownNCT05094765Early Phase 1
• Epigenetic and Microbiota ModificationsCompletedNCT05076656Early Phase 1
• Fecal Microbiota Transplantation for Carbapenem Resistant EnterobacteriaceaeCompletedNCT04790565Phase 2/3
• Fecal Microbial Transplantation in Severe Alcoholic HepatitisStatus unknownNCT04758806Phase 3
• Randomized Clinical Trial of Standard FMT TreatmentsWithdrawnNCT04729790Phase 2
• Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic DermatitisCompletedNCT04613037Early Phase 1
• Fecal Microbiota Transplantation as a Treatment for Ulcerative ColitisTerminatedNCT04434872Phase 2
• Effect of Gut Microbiome Restoration on Primary Hypertension Via FMTStatus unknownNCT04406129Early Phase 1
• A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver DiseaseWithdrawnNCT04371653Phase 2
• Fecal Microbial Transplantation for Ileal Pouch Anal Anastomosis PatientsStatus unknownNCT04336319Phase 2
• Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic DermatitisStatus unknownNCT04283968Phase 3
• Fecal Microbiota Transplantation for Carbapenem-resistant EnterobacteriaceaeCompletedNCT04146337Phase 2/3
• Explore Efficacy of FMT Treating Childhood ASD PatientsTerminatedNCT04142255Early Phase 1
• FMT In High-Risk Acute GVHD After ALLO HCTCompletedNCT04139577Phase 1
• Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1CompletedNCT04130763Phase 1
• Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.Status unknownNCT04116775Phase 2
• Fecal Microbiota TransplantCompletedNCT04090346Phase 4
• A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic MesotheliomaCompletedNCT04056026Early Phase 1
• Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's DiseaseTerminatedNCT03998423Phase 1
• Fecal Transplant for Ulcerative ColitisCompletedNCT03948919Phase 1
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)WithdrawnNCT03829878Phase 2
• Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)Active, not recruitingNCT03772899Phase 1
• FMT and Fiber in Patients With Metabolic SyndromeCompletedNCT03727321Phase 2
• Study of the Fecal Microbiome in Patients With Parkinson's DiseaseCompletedNCT03671785Phase 1
• Fecal Microbial Transplantation and Fiber Supplementation in Participants With Obesity and Metabolic Syndrome.CompletedNCT03477916Phase 2
• Fecal Transplant for Hepatic EncephalopathyCompletedNCT03439982Phase 1/2
• Fecal Microbial Transplant for Alcohol Misuse in CirrhosisCompletedNCT03416751Phase 1
• Fecal Microbiota Transplantation for ConstipationCompletedNCT03308461Not applicable
• Fecal Microbiota Transplantation in DepressionTerminatedNCT03281044Phase 2
• Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate ColitisCompletedNCT03268213Early Phase 1
• Fecal Microbial Transplantation in Patients With Crohn's DiseaseCompletedNCT03267238Early Phase 1
• FMT in Pediatric Crohn's DiseaseCompletedNCT03194529Phase 1/2
• Oral Fecal Transplant in CirrhosisCompletedNCT03152188Phase 1
• Fecal Transplant for Crohn's DiseaseCompletedNCT03078803Phase 2
• A Novel Faecal Microbiota Transplantation System for Treatment of Primary and Recurrent Clostridium Difficile InfectionStatus unknownNCT03053505Not applicable
• FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?CompletedNCT03029078Phase 4
• Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease PatientsWithdrawnNCT03026231Phase 1/2
• Fecal Microbiota Transplantation for Decompensated CirrhosisStatus unknownNCT03014505Phase 1/2
• Microbiota Restoration Therapy in HIV With Repeated Low-Dose InterventionsCompletedNCT03008941Phase 1/2
• EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota TransplantWithdrawnNCT02968511Not applicable
• Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic PatientsCompletedNCT02960074Phase 1
• FMT for MDRO Colonization After Infection in Renal Transplant RecipientsTerminatedNCT02922816Phase 1
• Effect of Fecal Microbiota Transplantation in Irritable Bowel SyndromeCompletedNCT02788071Phase 2/3
• Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.Status unknownNCT02721264Not applicable

← Fecal microbiota overview